ANI Pharma (ANIP) Misses Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GMAB
8. USO
9. GOOGL
10. AMD

Go back to ANI Pharma (ANIP) Misses Q2 EPS by 1c

ANI Pharmaceuticals Reports Second Quarter 2021 Results

August 6, 2021 7:24 AM EDT

-- Second quarter 2021 net revenues of $48.6 million; net loss of $14.1 million and diluted loss per share of ($1.17) --

-- Second quarter adjusted non-GAAP EBITDA of $13.1 million and adjusted non-GAAP diluted earnings per share of $0.67 --

-- Refiled supplemental new drug application (sNDA) for Cortrophin Gel with U.S Food and Drug Administration (FDA) on June 29, 2021; goal date is October 29, 2021 --

-- Pending acquisition of Novitium Pharma LLC on track to close in second half 2021--

-- Expanded branded products... More